Boston Scientific announced Monday that it is collaborating with Royal Philips Electronics through which the Dutch company will sell Boston Scientific Imaging equipment compatible with its imaging systems globally.Specifically, the marketing and distribution agreement relates to Boston Scientific’s iLabs ultrasound imaging system and its imaging catheters, which will now be sold with Philips’Allura Xper catheterization [...]

The Patient Protection and Affordable Care Act (ACA) includes a new 2.3% tax on the U.S. sale of medical devices beginning in 2013. The tax was included to raise $20 billion in revenue to partially offset the cost of the new, $1 trillion health program. The 2.3 percent tax is imposed on revenue, not profits, [...]

Implanted cardioverter defibrillators, which shock the heart back to life when a person suffers heart failure, have been plagued with controversy.In recent years, there has been federal scrutiny of relationships between doctors and device makers, and a drop in physicians implanting ICDs after an article in an influential medical journal said they are overutilized.But perhaps [...]

Last week, Boston Scientific announced that it was acquiring Cameron Health, a maker of a novel implanted cardioverter defibrillator system for $150 million upfront and the potential of up to $1.2 billion in milestone payments, including an approval from U.S. regulators.The maturity of the startup is likely a foreshadowing of a trend in the medical [...]

 Boston Scientific (NYSE:BSX) announced late Wednesday that the U.S. Food and Drug Administration has approved two drug-coated stent systems for heart attack patients. These are the first stents in the world to be cleared for patients suffering from the symptoms of acute myocardial infarction (AMI) or heart attack.The stents are the Ion and Taxus Libert [...]

Johnson & Johnson (NYSE:JNJ) has lost a court battle over its drug-coated stent patents after a New Jersey federal judge ruled that stents marketed by Boston Scientific (NYSE:BSX) Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) had not infringed stent patents held by the New Brunswick, New Jersey company.Despite the ruling, a Johnson & Johnson spokeswoman said [...]

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com. Now here’s the best of what YOU had to say.

A look at how Boston Scientific has shaped the emerging med tech landscape, and where the ex-BSC-ers are making their impact now.

Johnson & Johnson’s (NYSE:JNJ) Michael Mahoney will begin leading Boston Scientific (NYSE:BSX) in October, first as president and then begin his tenure at CEO in November. Mahoney joins Boston Scientific at a challenging time, as the company struggles with limited growth in its heart device markets, which generate 70 percent of its total [...]

Paulson & Co. Inc. is Boston Scientific Corp.’s (NYSE:BSX) largest shareholder no more, after liquidating its position in BSX completely by selling off some 15 million shares of the Natick, Mass.-based medical device company during the second quarter.The New York-based fund has been steadily selling off its BSX shares for more than [...]